Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22021
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCheng, Bastian-
dc.contributor.authorBoutitie, Florent-
dc.contributor.authorNickel, Alina-
dc.contributor.authorWouters, Anke-
dc.contributor.authorCho, Tae-Hee-
dc.contributor.authorEbinger, Martin-
dc.contributor.authorEndres, Matthias-
dc.contributor.authorFiebach, Jochen B-
dc.contributor.authorFiehler, Jens-
dc.contributor.authorGalinovic, Ivana-
dc.contributor.authorPuig, Josep-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorLemmens, Robin-
dc.contributor.authorMuir, Keith W-
dc.contributor.authorNighoghossian, Norbert-
dc.contributor.authorPedraza, Salvador-
dc.contributor.authorSimonsen, Claus Z-
dc.contributor.authorGerloff, Christian-
dc.contributor.authorThomalla, Götz-
dc.date2019-10-30-
dc.date.accessioned2019-11-06T04:04:39Z-
dc.date.available2019-11-06T04:04:39Z-
dc.date.issued2020-01-
dc.identifier.citationStroke 2020; 51(1): 209-215-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22021-
dc.description.abstractBackground and Purpose- Relative signal intensity of acute ischemic stroke lesions in fluid-attenuated inversion recovery (fluid-attenuated inversion recovery relative signal intensity [FLAIR-rSI]) magnetic resonance imaging is associated with time elapsed since stroke onset with higher intensities signifying longer time intervals. In the randomized controlled WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke Trial), intravenous alteplase was effective in patients with unknown onset stroke selected by visual assessment of diffusion weighted imaging fluid-attenuated inversion recovery mismatch, that is, in those with no marked fluid-attenuated inversion recovery hyperintensity in the region of the acute diffusion weighted imaging lesion. In this post hoc analysis, we investigated whether quantitatively measured FLAIR-rSI modifies treatment effect of intravenous alteplase. Methods- FLAIR-rSI of stroke lesions was measured relative to signal intensity in a mirrored region in the contralesional hemisphere. The relationship between FLAIR-rSI and treatment effect on functional outcome assessed by the modified Rankin Scale (mRS) after 90 days was analyzed by binary logistic regression using different end points, that is, favorable outcome defined as mRS score of 0 to 1, independent outcome defined as mRS score of 0 to 2, ordinal analysis of mRS scores (shift analysis). All models were adjusted for National Institutes of Health Stroke Scale at symptom onset and stroke lesion volume. Results- FLAIR-rSI was successfully quantified in stroke lesions in 433 patients (86% of 503 patients included in WAKE-UP). Mean FLAIR-rSI was 1.06 (SD, 0.09). Interaction of FLAIR-rSI and treatment effect was not significant for mRS score of 0 to 1 (P=0.169) and shift analysis (P=0.086) but reached significance for mRS score of 0 to 2 (P=0.004). We observed a smooth continuing trend of decreasing treatment effects in relation to clinical end points with increasing FLAIR-rSI. Conclusions- In patients in whom no marked parenchymal fluid-attenuated inversion recovery hyperintensity was detected by visual judgement in the WAKE-UP trial, higher FLAIR-rSI of diffusion weighted imaging lesions was associated with decreased treatment effects of intravenous thrombolysis. This parallels the known association of treatment effect and elapsing time of stroke onset.-
dc.language.isoeng-
dc.subjectbrain ischemia-
dc.subjecthumans-
dc.subjectlogistic models-
dc.subjectmagnetic resonance imaging-
dc.subjectStroke volume-
dc.titleQuantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial.-
dc.typeJournal Articleen_US
dc.identifier.journaltitleStroke-
dc.identifier.affiliationKlinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany-
dc.identifier.affiliationCNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne, Franceen
dc.identifier.affiliationStroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Neurology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germanyen
dc.identifier.affiliationCentrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Campus Mitte, Germanyen
dc.identifier.affiliationKlinik und Hochschulambulanz für Neurologie, Charité-Universitätsmedizin Berlin, Germanyen
dc.identifier.affiliationNeurologie der Rehaklinik Medical Park Humboldtmühle, Berlin, Germanyen
dc.identifier.affiliationService de Biostatistique, Hospices Civils de Lyon, Franceen
dc.identifier.affiliationUniversité Lyon 1, Villeurbanne, Franceen
dc.identifier.affiliationDepartment of Stroke Medicine, Université Claude Bernard Lyon 1, CREATIS CNRS UMR 5220-INSERM U1206, INSA-Lyon, Franceen
dc.identifier.affiliationHospices Civils de Lyon, Franceen
dc.identifier.affiliationDepartment of Neurology, University Hospitals Leuven, Belgiumen
dc.identifier.affiliationDepartment of Neurosciences, Experimental Neurology, KU Leuven-University of Leuven, Belgiumen
dc.identifier.affiliationVIB, Center for Brain and Disease Research, Laboratory of Neurobiology, Campus Gasthuisberg, Leuven, Belgiumen
dc.identifier.affiliationFrom the Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany-
dc.identifier.affiliationCentrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Campus Mitte, Germany-
dc.identifier.affiliationDepartment of Radiology, Institut de Diagnostic per la Image, Hospital Dr Josep Trueta, Institut d'Investigació Biomèdica de Girona, Parc Hospitalari Martí i Julià de Salt, Girona, Spain-
dc.identifier.affiliationInstitute of Neuroscience and Psychology, University of Glasgow, United Kingdom-
dc.identifier.affiliationDepartment of Radiology, Institut de Diagnostic per la Image, Hospital Dr Josep Trueta, Institut d'Investigació Biomèdica de Girona, Parc Hospitalari Martí i Julià de Salt, Girona, Spain-
dc.identifier.affiliationDepartment of Neurology, Aarhus University Hospital, Denmark-
dc.identifier.affiliationFrom the Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany-
dc.identifier.doi10.1161/STROKEAHA.119.027390-
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-6614-8417-
dc.identifier.pubmedid31662118-
dc.type.austinJournal Article-
local.name.researcherThijs, Vincent N
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptNeurology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

70
checked on Jan 14, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.